Robert Gniadecki

Medicine & Life Sciences

1. Cutaneous T-Cell Lymphoma 100%
2. Psoriasis 95%
3. Mycosis Fungoides 85%
4. Skin 46%
5. MicroRNAs 32%
6. Basal Cell Carcinoma 29%
7. Adalimumab 26%
8. T-Lymphocytes 26%
9. Atopic Dermatitis 25%
10. Melanoma 22%
11. Therapeutics 21%
12. Lymphoma 20%
13. Apoptosis 19%
14. Ustekinumab 19%
15. Etanercept 18%
16. Psoriatic Arthritis 18%
17. Neoplasms 17%
18. secukinumab 16%
19. T-Cell Antigen Receptor 16%
20. Photopheresis 15%
21. Skin Diseases 15%
22. Dermatology 14%
23. Primary Cutaneous Anaplastic Large Cell Lymphoma 13%
24. Cohort Studies 12%
25. Ficusin 12%
26. Biological Products 11%
27. Skin Neoplasms 11%
28. Safety 11%
29. nutlin 3 11%
30. Electrons 10%
31. Biological Factors 10%
32. Ubiquitin-Specific Proteases 10%
33. Quality of Life 10%
34. Nevus 10%
35. T-Cell Lymphoma 10%
36. Cutaneous Malignant Melanoma 10%
37. Keratinocytes 9%
38. Hidradenitis Suppurativa 9%
39. Denmark 9%
40. Survival 9%
41. Mohs Surgery 9%
42. Cancer-Associated Fibroblasts 9%
43. Pigmented Nevus 9%
44. Interleukin-17 9%
45. Cell Line 8%
46. AVX001 8%
47. STAT3 Transcription Factor 8%
48. Retrospective Studies 8%
49. Radiation 8%
50. Pharmaceutical Preparations 7%